首页> 外国专利> TARGETING INTERLEUKIN-3 (IL-3) IN SEPSIS

TARGETING INTERLEUKIN-3 (IL-3) IN SEPSIS

机译:在脓毒症中靶向白介素3(IL-3)

摘要

Methods for diagnosing, treating, and reducing the risk of developing sepsis, by measuring or targeting interleukin 3 (IL-3). The present invention is based, at least in part, on the discovery that the cytokine interleukin (IL)-3 potentiates inflammation in sepsis. Thus, described herein are methods for diagnosing sepsis, severe sepsis, or septic shock in a subject. Also provided herein are methods for predicting risk of mortality in a subject with sepsis, severe sepsis, or septic shock. Also provided herein are methods for monitoring the condition or risk of mortality in a subject with sepsis, severe sepsis, or septic shock. In addition, provided herein are methods for determining the efficacy of a treatment for sepsis, severe sepsis, or septic shock.
机译:通过测量或靶向白介素3(IL-3)来诊断,治疗和降低败血症发生风险的方法。本发明至少部分基于以下发现:细胞因子白介素(IL)-3增强败血症中的炎症。因此,本文描述了用于诊断受试者的败血症,严重败血症或败血性休克的方法。本文还提供了用于预测患有败血症,严重败血症或败血性休克的受试者中死亡风险的方法。本文还提供了用于监测患有败血症,严重败血症或败血性休克的受试者的状况或死亡风险的方法。另外,本文提供了确定败血症,严重败血症或败血性休克的治疗功效的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号